How many times were you consulted on or followed up on a child with cancer with one of the following issues: hypertension, acute kidney injury, proteinuria, hematuria, fluid and electrolyte imbalances, tumor lysis syndrome, kidney and urinary tract infections, kidney tumor, on nephrotoxic medications, stem cell or bone marrow transplant, thrombotic microangiopathy, or chronic kidney disease (CKD)? All the time, right? With advances in cancer therapies and development of novel treatments like CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy and vascular endothelial growth factor (VEGF)-targeted therapy, challenges have only increased. Since the first onco-nephrology forum at ASN Kidney Week
International medical graduates (IMGs) play an important role in the US healthcare delivery system. About a quarter of the 800,000 practicing physicians are IMGs, and 41% of practicing IMGs are in primary care disciplines (1). These physicians play a vital role in the care of vulnerable populations in the underserved areas of both urban and rural settings. In a survey conducted in pediatrics, international IMGs are more likely to work in underserved areas than are American medical school graduates (2).
About 18% of graduating pediatric residents are IMGs, and about 25% of fellows